Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Feb;81(2):461–465. doi: 10.1172/JCI113342

Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.

H S Tenenhouse 1, A Yip 1, G Jones 1
PMCID: PMC329592  PMID: 3339128

Abstract

The hypophosphatemic (Hyp) mouse, a murine homologue of human X-linked hypophosphatemic rickets, is characterized by renal defects in brush border membrane phosphate transport and vitamin D3 metabolism. The present study was undertaken to examine whether elevated renal 25-hydroxyvitamin D3-24-hydroxylase activity in Hyp mice is associated with increased degradation of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] by side chain oxidation. Metabolites of 1,25(OH)2D3 were separated by HPLC on Zorbax SIL and identified by comparison with standards authenticated by mass spectrometry. Production of 1,24,25-trihydroxyvitamin D3, 24-oxo-1,25-dihydroxyvitamin D3, and 24-oxo-1,23,25-trihydroxyvitamin D3 was twofold greater in mitochondria from mutant Hyp/Y mice than from normal +/Y littermates. Enzyme activities, estimated by the sum of the three products synthesized per milligram mitochondrial protein under initial rate conditions, were used to estimate kinetic parameters. The apparent Vmax was significantly greater for mitochondria from Hyp/Y mice than from +/Y mice (0.607 +/- 0.064 vs. 0.290 +/- 0.011 pmol/mg per protein per min, mean +/- SEM, P less than 0.001), whereas the apparent Michaelis-Menten constant (Km) was similar in both genotypes (23 +/- 2 vs. 17 +/- 5 nM). The Km for 1,25(OH)2D3 was approximately 10-fold lower than that for 25-hydroxyvitamin D3 [25(OH)D3], indicating that 1,25(OH)2D3 is perhaps the preferred substrate under physiological conditions. In both genotypes, apparent Vmax for 25(OH)D3 was fourfold greater than that for 1,25(OH)2D3, suggesting that side chain oxidation of 25(OH)D3 may operate at pharmacological concentrations of substrate. The present results demonstrate that Hyp mice exhibit increased renal catabolism of 1,25(OH)2D3 and suggest that elevated degradation of vitamin D3 hormone may contribute significantly to the clinical phenotype in this disorder.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  2. Chesney R. W., Mazess R. B., Rose P., Hamstra A. J., DeLuca H. F. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets. Am J Dis Child. 1980 Feb;134(2):140–143. doi: 10.1001/archpedi.1980.02130140014005. [DOI] [PubMed] [Google Scholar]
  3. Cunningham J., Gomes H., Seino Y., Chase L. R. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse. Endocrinology. 1983 Feb;112(2):633–638. doi: 10.1210/endo-112-2-633. [DOI] [PubMed] [Google Scholar]
  4. Eicher E. M., Southard J. L., Scriver C. R., Glorieux F. H. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4667–4671. doi: 10.1073/pnas.73.12.4667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Esvelt R. P., Schnoes H. K., DeLuca H. F. Isolation and characterization of 1 alpha-hydroxy-23-carboxytetranorvitamin D: a major metabolite of 1,25-dihydroxyvitamin D3. Biochemistry. 1979 Sep 4;18(18):3977–3983. doi: 10.1021/bi00585a021. [DOI] [PubMed] [Google Scholar]
  6. Fraser D. R. Regulation of the metabolism of vitamin D. Physiol Rev. 1980 Apr;60(2):551–613. doi: 10.1152/physrev.1980.60.2.551. [DOI] [PubMed] [Google Scholar]
  7. Gray R. W., Napoli J. L. Dietary phosphate deprivation increases 1,25-dihyroxyvitamin D3 synthesis in rat kidney in vitro. J Biol Chem. 1983 Jan 25;258(2):1152–1155. [PubMed] [Google Scholar]
  8. Harrell R. M., Lyles K. W., Harrelson J. M., Friedman N. E., Drezner M. K. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest. 1985 Jun;75(6):1858–1868. doi: 10.1172/JCI111900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jones G. A new pathway of 25-hydroxyvitamin D3 metabolism. Methods Enzymol. 1986;123:141–154. doi: 10.1016/s0076-6879(86)23017-7. [DOI] [PubMed] [Google Scholar]
  10. Jones G. Chromatographic separation of 24(R),25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3-26,23-lactone using a cyano-bonded phase packing. J Chromatogr. 1983 Aug 12;276(1):69–75. [PubMed] [Google Scholar]
  11. Jones G., Kano K., Yamada S., Furusawa T., Takayama H., Suda T. Identification of 24,25,26,27-tetranor-23-hydroxyvitamin D3 as a product of the renal metabolism of 24,25-dihydroxyvitamin D3. Biochemistry. 1984 Jul 31;23(16):3749–3754. doi: 10.1021/bi00311a028. [DOI] [PubMed] [Google Scholar]
  12. Lobaugh B., Drezner M. K. Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. J Clin Invest. 1983 Feb;71(2):400–403. doi: 10.1172/JCI110783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mayer E., Bishop J. E., Chandraratna R. A., Okamura W. H., Kruse J. R., Popjak G., Ohnuma N., Norman A. W. Isolation and identification of 1,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3. New metabolites of vitamin D3 produced by a C-24 oxidation pathway of metabolism for 1,25-dihydroxyvitamin D3 present in intestine and kidney. J Biol Chem. 1983 Nov 25;258(22):13458–13465. [PubMed] [Google Scholar]
  14. Meyer R. A., Jr, Gray R. W., Meyer M. H. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology. 1980 Nov;107(5):1577–1581. doi: 10.1210/endo-107-5-1577. [DOI] [PubMed] [Google Scholar]
  15. Napoli J. L., Horst R. L. C(24)- and C(23)-oxidation, converging pathways of intestinal 1,25-dihydroxyvitamin D3 metabolism: identification of 24-keto-1,23,25-trihydroxyvitamin D3. Biochemistry. 1983 Dec 6;22(25):5848–5853. doi: 10.1021/bi00294a025. [DOI] [PubMed] [Google Scholar]
  16. Nesbitt T., Drezner M. K., Lobaugh B. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism. J Clin Invest. 1986 Jan;77(1):181–187. doi: 10.1172/JCI112274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reddy G. S., Tserng K. Y., Thomas B. R., Dayal R., Norman A. W. Isolation and identification of 1,23-dihydroxy-24,25,26,27-tetranorvitamin D3, a new metabolite of 1,25-dihydroxyvitamin D3 produced in rat kidney. Biochemistry. 1987 Jan 13;26(1):324–331. doi: 10.1021/bi00375a045. [DOI] [PubMed] [Google Scholar]
  18. Scriver C. R., Reade T. M., DeLuca H. F., Hamstra A. J. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med. 1978 Nov 2;299(18):976–979. doi: 10.1056/NEJM197811022991803. [DOI] [PubMed] [Google Scholar]
  19. Tanaka Y., Deluca H. F. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys. 1973 Feb;154(2):566–574. doi: 10.1016/0003-9861(73)90010-6. [DOI] [PubMed] [Google Scholar]
  20. Tenenhouse H. S. Abnormal renal mitochondrial 25-hydroxyvitamin D3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse. Endocrinology. 1983 Aug;113(2):816–818. doi: 10.1210/endo-113-2-816. [DOI] [PubMed] [Google Scholar]
  21. Tenenhouse H. S. Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse. Endocrinology. 1984 Aug;115(2):634–639. doi: 10.1210/endo-115-2-634. [DOI] [PubMed] [Google Scholar]
  22. Tenenhouse H. S., Jones G. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase. Endocrinology. 1987 Feb;120(2):609–616. doi: 10.1210/endo-120-2-609. [DOI] [PubMed] [Google Scholar]
  23. Tenenhouse H. S. Metabolism of 25-hydroxyvitamin D3 in renal slices from the X-linked hypophosphatemic (Hyp) mouse: abnormal response to fall in serum calcium. Cell Calcium. 1984 Feb;5(1):43–55. doi: 10.1016/0143-4160(84)90153-2. [DOI] [PubMed] [Google Scholar]
  24. Tenenhouse H. S., Scriver C. R., McInnes R. R., Glorieux F. H. Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. Kidney Int. 1978 Sep;14(3):236–244. doi: 10.1038/ki.1978.115. [DOI] [PubMed] [Google Scholar]
  25. Tenenhouse H. S., Scriver C. R. The defect in transcellular transport of phosphate in the nephron is located in brush-border membranes in X-linked hypophosphatemia (Hyp mouse model). Can J Biochem. 1978 Jun;56(6):640–646. doi: 10.1139/o78-096. [DOI] [PubMed] [Google Scholar]
  26. Vieth R., Fraser D. Kinetic behavior of 25-hydroxyvitamin D-1-hydroxylase and -24-hydroxylase in rat kidney mitochondria. J Biol Chem. 1979 Dec 25;254(24):12455–12460. [PubMed] [Google Scholar]
  27. Yamaoka K., Seino Y., Satomura K., Tanaka Y., Yabuuchi H., Haussler M. R. Abnormal relationship between serum phosphate concentration and renal 25-hydroxycholecalciferol-1-alpha-hydroxylase activity in X-linked hypophosphatemic mice. Miner Electrolyte Metab. 1986;12(3):194–198. [PubMed] [Google Scholar]
  28. Zuber M. X., Simpson E. R., Waterman M. R. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science. 1986 Dec 5;234(4781):1258–1261. doi: 10.1126/science.3535074. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES